Showing results (61-70 of 73) with videos related to
Sort By:
Pageof 8
Annals of the Rheumatic Diseases|September 4, 2008
Type I interferons might form the link between Toll-like receptor (TLR) 3/7 and TLR4-mediated synovial inflammation in rheumatoid arthritis (RA)M F Roelofs, M H Wenink, F Brentano, et al.Scandinavian Journal of Rheumatology|March 4, 2009
Enhanced interleukin-10 production by dendritic cells upon stimulation with Toll-like receptor 4 agonists in systemic sclerosis that is possibly implicated in CCL18 secretionA W T van Lieshout, M C Vonk, S J H Bredie, et al.Arthritis Care & Research|January 28, 2015
Effect of Aerobic Exercise Training on Fatigue in Rheumatoid Arthritis: A Meta-AnalysisS A A Rongen-van Dartel, H Repping-Wuts, M Flendrie, et al.Annals of the Rheumatic Diseases|December 3, 2003
Efficacy and safety of the fully human anti-tumour necrosis factor alpha monoclonal antibody adalimumab (D2E7) in DMARD refractory patients with rheumatoid arthritis: a 12 week, phase II studyL B A van de Putte, R Rau, F C Breedveld, et al.Annals of the Rheumatic Diseases|July 19, 2008
Anti-inflammatory therapy with tumour necrosis factor alpha inhibitors improves high-density lipoprotein cholesterol antioxidative capacity in rheumatoid arthritis patientsC Popa, L J H van Tits, P Barrera, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|September 18, 2014
An increased risk of non-melanoma skin cancer during TNF-inhibitor treatment in psoriasis patients compared to rheumatoid arthritis patients probably relates to disease-related factorsP P M van Lümig, S P Menting, J M P A van den Reek, et al.Annals of the Rheumatic Diseases|March 5, 2002
Long term anti-tumour necrosis factor alpha monotherapy in rheumatoid arthritis: effect on radiological course and prognostic value of markers of cartilage turnover and endothelial activationA A den Broeder, L A B Joosten, T Saxne, et al.Annals of the Rheumatic Diseases|April 15, 2004
Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failedL B A van de Putte, C Atkins, M Malaise, et al.Annals of the Rheumatic Diseases|April 4, 2008
The tumour necrosis factor receptor superfamily member 1b 676T>G polymorphism in relation to response to infliximab and adalimumab treatment and disease severity in rheumatoid arthritisE J M Toonen, M J H Coenen, W Kievit, et al.Osteoarthritis and Cartilage|March 21, 2012
Prevalence and predictors of health care use in patients with early hip or knee osteoarthritis: two-year follow-up data from the CHECK cohortT J Hoogeboom, G F Snijders, H A Cats, et al.Pageof 8